Login to Your Account



Other News To Note


Friday, May 17, 2013
• Oxygen Biotherapeutics Inc., of Morrisville, N.C., said the Nasdaq Listing Qualifications Panel granted the company's request for continued listing on the Nasdaq Capital Market through June 3 to comply with the minimum $1 bid price requirement and through July 31 to comply with the minimum $2.5 million stockholders' equity requirement.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription